European Parliament · 25 November 2020
Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron
Adopted
425 in favour · 231 against · 40 abstained. 696 members voted.
What it asks for, in the Parliament's words
- Calls on the Commission to withdraw the approvals for substances if proof or reasonable doubt exists that they will not meet the safety criteria laid down in Regulation (EC) No 1107/2009
- Considers that Implementing Regulation (EU) 2020/1511 does not respect the precautionary principle
- Considers that Implementing Regulation (EU) 2020/1511 exceeds the implementing powers provided for in Regulation (EC) No 1107/2009
Quoted from B9-0367/2020, which says more than these lines. Each is a whole paragraph; this site does not rewrite them.
See how every country and every MEP voted